Pfizer CEO Albert Bourla tests positive for COVID-19 for the second time in less than 2 months
Check out what’s clicking on FoxBusiness.com
Pfizer Chairman and CEO Albert Bourla said on Saturday that this has tested positive for COVID-19 for the second time in less than two months.
Bourla, who heads the company that helped create the widely used Pfizer-BioNTech coronavirus vaccine, said he was feeling well and symptom-free.
“I haven’t gotten the new bivalent booster yet, as I followed CDC guidelines to wait 3 months since my last COVID case, which was back in mid-August,”[ads1]; Bourla said.
“Although we have made great progress, the virus is still with us,” Bourla added.
Bourla previously announced on August 14 that he tested positive for the virus and was experiencing mild symptoms.
PFIZER TO PROVIDE UP TO 6 MILLION COURSES OF COVID-19 TREATMENT FOR LOWER INCOME COUNTRIES
NEW YORK, NY – NOVEMBER 9: Albert Bourla attends the New York Times DealBook Online Summit on November 9, 2021 in New York City. (Photo by Ryan Muir/Getty Images via The New York Times) (Ryan Muir/Getty Images via The New York Times/Getty Images)
Late last month, the US Food and Drug Administration (FDA) announced that it has authorized updated coronavirus booster shots targeting the highly contagious omicron variant.
| Ticker | Safety | Last | Change | Change % |
|---|---|---|---|---|
| PFE | PFIZER INC. | 44.08 | -0.49 | -1.10% |
“As we head into fall and begin spending more time indoors, we strongly encourage everyone who is eligible to consider getting a booster dose of a bivalent COVID-19 vaccine to provide better protection against circulating variants,” said FDA Commissioner Robert Califf in a statement at the time.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
The shots, which the FDA refers to as “updated boosters,” contain “two messenger RNA (mRNA) components of the SARS-CoV-2 virus, one of the original strain of SARS-CoV-2 and the other shared between BA. 4 and BA.5 lineages of the omicron variant of SARS-CoV-2.”
